Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Solid Tumor, Adult

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Wenming Wu, PhD) · doctorwuu@126.com · +8613811138595

Study leads

Wenming Wu, PhD
Principal Investigator
Peking Union Medical College Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Beta-only IL-2 ImmunoTherapY Study

Advanced Solid Tumor · Unresectable Solid Tumor · Clear Cell Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Diego, United States · San Francisco, United States

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Solid Tumor, Adult

Abroad (travel likely)RecruitingPHASE2

Albury, Australia · Albury, Australia

First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors

Solid Tumor, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Dijon, France · Montpellier, France

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Solid Tumor · Non-Small-Cell Lung Cancer · Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Santa Monica, United States · Atlanta, United States